Tel Aviv - Delayed Quote • ILA Allmed Solutions Ltd (ALMD.TA) Follow Compare 32.70 +0.70 +(2.19%) As of 3:24:55 PM GMT+2. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Vote of confidence in TruLeaf Medical, subsidiary of AllMeD Solutions: 11.5 million NIS grant awarded by the Israel Innovation Authority The Israel Innovation Authority, part of the Ministry of Economy and Industry, approved an additional grant of approximately NIS 1.5 million (approx. $410,000) to TruLeaf Medical as part of the Minimally Invasive Transcatheter Mitral Valve Replacement program. This is the 6th time TruLeaf has received the grant, bringing the total to approximately NIS 11.5 million (approx. $3.14 million). A New Era in Heart Surgery - Israeli Biomed Company TruLeaf Medical's Two Needle Sticks Procedure for Mitral Valve Replacement AllMeD Solutions announced subsidiary TruLeaf Medical's receipt of the Helsinki Ethics Committee's approval in Uzbekistan to conduct clinical trial in human subjects. As part of the trial, a prosthetic mitral valve will be implanted via two needle sticks in the groins in a two-stage catheterization procedure without the need for open-heart surgery (transcatheter mitral valve replacement, TMVR). The implantation of the innovative platform (the RoseDoc) developed by TruLeaf, which replaces the pat Performance Overview Trailing total returns as of 1/19/2025, which may include dividends or other distributions. Benchmark is TA-125 Return ALMD.TA TA-125 YTD -3.82% +8.46% 1-Year -14.17% +38.98% 3-Year -28.29% +22.61%